Tenaya Therapeutics (TNYA) Other Non Operating Income (2020 - 2025)
Tenaya Therapeutics' quarterly Other Non Operating Income came in at $25000.0 in Q4 2025, up 525.0% year-on-year from $4000.0 in Q4 2024, and up 733.33% quarter-over-quarter from $3000.0 in Q3 2025.
Tenaya Therapeutics has reported Other Non Operating Income for 6 years, with the latest figure at $25000.0 in Q4 2025.
- For the quarter ending Q4 2025, Other Non Operating Income rose 525.0% year-over-year to $25000.0; the trailing twelve-month figure through Dec 2025 stood at $51000.0 (down 37.8% YoY), and the FY2025 full-year result was $52000.0, down 36.59% from the prior year.
- Other Non Operating Income for Q4 2025 stood at $25000.0, up from $3000.0 in the prior quarter.
- The five-year high for Other Non Operating Income was $82000.0 in Q1 2024, with the low at -$54000.0 in Q4 2021.
- Average Other Non Operating Income over 5 years is $8684.2, with a median of $3000.0 recorded in 2025.
- Peak annual rise in Other Non Operating Income reached 1600.0% in 2021, while the deepest fall reached 5300.0% in 2021.
- Tracing TNYA's Other Non Operating Income over 5 years: stood at -$54000.0 in 2021, then surged by 94.44% to -$3000.0 in 2022, then surged by 1466.67% to $41000.0 in 2023, then slumped by 90.24% to $4000.0 in 2024, then soared by 525.0% to $25000.0 in 2025.
- The last three Other Non Operating Income figures came in at $25000.0 (Q4 2025), $3000.0 (Q3 2025), and -$16000.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Tenaya Therapeutics | 193.57 Mn | 193.57 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 25,000.00 |
| Sep 30, 2025 | 3,000.00 |
| Jun 30, 2025 | -16,000.00 |
| Mar 31, 2025 | 39,000.00 |
| Dec 31, 2024 | 4,000.00 |
| Sep 30, 2024 | -3,000.00 |
| Jun 30, 2024 | -1,000.00 |
| Mar 31, 2024 | 82,000.00 |
| Dec 31, 2023 | 41,000.00 |
| Sep 30, 2023 | 1,000.00 |
| Jun 30, 2023 | -2,000.00 |
| Mar 31, 2023 | 13,000.00 |
| Dec 31, 2022 | -3,000.00 |
| Sep 30, 2022 | 6,000.00 |
| Mar 31, 2022 | -1,000.00 |
| Dec 31, 2021 | -54,000.00 |
| Sep 30, 2021 | 15,000.00 |
| Jun 30, 2021 | 18,000.00 |
| Mar 31, 2021 | -2,000.00 |
| Dec 31, 2020 | -1,000.00 |
| Sep 30, 2020 | -1,000.00 |
| Jun 30, 2020 | 180,000.00 |